An atlas of oesophageal cancer development

From the team taking on our Cancer Causes challenge, a new integrated atlas of the stromal and epithelial interactions that drive cancers associated with chronic inflammation provides a new way to understand cancer types with the poorest survival. Inflammation – the immune system’s normal response

Cancer Research Institute Names Newest Class of Lloyd J. Old STARs, Today's Visionaries in Cancer Immunotherapy Research

The Cancer Research Institute (CRI), a nonprofit organization dedicated to the discovery and development of powerful immunotherapies for all types of cancer, announced today the newest cohort of scientists chosen for the CRI Lloyd J. Old STAR Program (Scientists Taking Risks). Each STAR will receive

2022 Precision Medicine World Conference Back In Person, Features Extensive UCSF Presence

For the seventh consecutive year, UC San Francisco is co-sponsoring the Precision Medicine World Conference (PMWC) on June 28-30, 2022, to share the latest in this rapidly evolving space. The conference will be held in person after being virtual for the past two years due to the pandemic and will

Understanding the Genesis of Cancer is Goal of $25 Million Award

A world-class team of researchers co-led by UC San Francisco’s Allan Balmain, PhD, FRS, has been selected to receive a $25 million Cancer Grand Challenges award to investigate the very early stages of cancer development. Cancer Grand Challenges is a global funding platform, co-founded by Cancer

Screening and Removal of Precancerous Lesions Prevents Anal Cancer

In a groundbreaking finding, a new study led by UC San Francisco found that routine screening for and removal of precancerous anal lesions can significantly reduce the risk of anal cancer, similar to the way cervical cancer is prevented in women. The national study is published June 16, 2022, in the

Sweet-Cordero Appointed Chief of the Division of Oncology in the Department of Pediatrics

Alejandro Sweet-Cordero, MD, has been appointed chief of the Division of Oncology in the Department of Pediatrics, effective June 6, 2022. Sweet-Cordero also is director of the Molecular Oncology Initiative and co-leader of the Pediatric Malignancies Program for the Cancer Center. The following is

3-D Mammography Technique Benefits Some Women, Not All

For many women, breast cancer screening with a 3-D imaging technique called digital breast tomosynthesis (DBT) may not offer advantages over digital mammography, but for some it may reduce the chance of an advanced cancer diagnosis, according to a new study published June 14 in Journal of the